Work

DOP078 Pharmacology and safety of etrasimod (APD334), an oral, potent, next-generation, selective S1P receptor modulator

Year: 2017

Type: conference-abstract

Source: Journal of Crohn s and Colitis

DOI: 10.1093/ecco-jcc/jjx002.115

Authors: T. Kühbacher, R. Christopher, L. Trokan, C. Lassen, J. Adams, L. Peyrin-Biroulet

Institutions: Christian-Albrechts-Universität zu Kiel, Asklepios, Arena Pharmaceuticals (United States), Centre Hospitalier Régional et Universitaire de Nancy, Université de Lorraine

Language: English

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586805442

Cites:

Cited by: 4

Related to: 10